A detailed history of Sompo Asset Management Co., Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Sompo Asset Management Co., Ltd. holds 1,200 shares of BIIB stock, worth $189,612. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,200
Previous 1,460 17.81%
Holding current value
$189,612
Previous $338,000 31.36%
% of portfolio
0.04%
Previous 0.06%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$189.07 - $236.8 $49,158 - $61,568
-260 Reduced 17.81%
1,200 $232,000
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $74,302 - $92,320
390 Added 36.45%
1,460 $338,000
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $226,861 - $286,449
1,070 New
1,070 $230,000
Q3 2023

Nov 09, 2023

BUY
$253.3 - $285.89 $278,630 - $314,479
1,100 New
1,100 $282,000
Q4 2022

Feb 01, 2023

BUY
$252.44 - $306.72 $239,818 - $291,384
950 New
950 $263,000
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $642,650 - $825,899
-2,870 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$282.99 - $369.05 $687,665 - $896,791
-2,430 Reduced 45.85%
2,870 $812,000
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $142,450 - $228,090
-550 Reduced 9.4%
5,300 $1.84 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $680,260 - $796,964
-2,800 Reduced 32.37%
5,850 $1.64 Million
Q4 2020

Feb 08, 2021

BUY
$236.26 - $355.63 $815,097 - $1.23 Million
3,450 Added 66.35%
8,650 $2.12 Million
Q3 2020

Nov 06, 2020

SELL
$264.77 - $305.71 $148,271 - $171,197
-560 Reduced 9.72%
5,200 $1.48 Million
Q2 2020

Aug 05, 2020

BUY
$258.66 - $342.55 $1.09 Million - $1.45 Million
4,220 Added 274.03%
5,760 $1.54 Million
Q1 2020

May 11, 2020

BUY
$268.85 - $341.04 $414,029 - $525,201
1,540 New
1,540 $487,000
Q3 2018

Nov 06, 2018

SELL
$293.51 - $383.83 $2.88 Million - $3.76 Million
-9,800 Closed
0 $0
Q2 2018

Aug 02, 2018

SELL
$257.52 - $306.91 $656,676 - $782,620
-2,550 Reduced 20.65%
9,800 $2.84 Million
Q1 2018

Apr 25, 2018

SELL
$260.13 - $367.91 $28,614 - $40,470
-110 Reduced 0.88%
12,350 $3.38 Million
Q4 2017

Feb 05, 2018

SELL
$307.64 - $344.58 $612,203 - $685,714
-1,990 Reduced 13.77%
12,460 $3.97 Million
Q3 2017

Nov 13, 2017

SELL
$281.15 - $329.69 $421,724 - $494,535
-1,500 Reduced 9.4%
14,450 $4.53 Million
Q2 2017

Jan 04, 2018

SELL
N/A
-2,910 Reduced 15.43%
15,950 $4.33 Million
Q1 2017

Jan 04, 2018

SELL
N/A
-390 Reduced 2.03%
18,860 $5.16 Million
Q4 2016

Jan 04, 2018

BUY
N/A
19,250
19,250 $5.46 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sompo Asset Management Co., Ltd. Portfolio

Follow Sompo Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sompo Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sompo Asset Management Co., Ltd. with notifications on news.